Michelson Diagnostics Ltd

Michelson Diagnostics Ltd. was formed in March 2006 by five physicists and engineers and is the world leader in practical OCT dermatology applications. Our flagship product, VivoSight Dx, is a state-of-the art Optical Coherence Tomography (OCT) system. It is a powerful, non-invasive and versatile imaging tool that provides objective measurement of multiple parameters in skin research and for advanced clinical practice. We believe in medical imaging & measurements to be a fundamental procedure leading to new discoveries, understanding and ultimately better treatments with unique products. VivoSight has been cited in over 350 peer reviewed publications. Our purpose is to realize...

Optical coherence tomography,microneedles,transdermal,atopic dermatitis,drug delivery,eczema,skin cancer,basal cell carcinoma,port wine stain,dermatology,medical imaging technology,diagnosis and monitoring of skin conditions,vascular imaging,vivosight,and oct

Michelson diagnostics ltd operates in the Medical equipment manufacturing industry.

Michelson diagnostics ltd's revenue is 11m - 100m

Michelson diagnostics ltd has 11 - 50 employees.